EN DE
STOCK COMPARISON

MEDIPOST Co. vs Bioneer: Fair Value & Quality

Both stocks run through our valuation models. Here is how MEDIPOST Co. (078160) and Bioneer (064550) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Bioneer as the more attractively valued of the two: MEDIPOST Co. trades at KRW 9,850 versus a fair value of KRW 3,628 (-63%), while Bioneer trades at KRW 6,910 versus KRW 8,312 (+20%).
MEDIPOST Co.
078160.KQ · KRW · Health Care
-63%
upside to fair value
overvalued
PriceKRW 9,850
Fair ValueKRW 3,628
Quality26/100
Bioneer
064550.KQ · KRW · Health Care
+20%
upside to fair value
undervalued
PriceKRW 6,910
Fair ValueKRW 8,312
Quality58/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

MEDIPOST Co.Bioneer
Profitability
4%Net margin10%
-26%Operating margin9%
-3%Return on assets5%
Growth
23%Revenue growth (YoY)-15%
4.7%Avg. growth/yr (3Y)14.8%
8.7%Avg. growth/yr (5Y)9.8%
Balance & size
0.03×Debt / equity0.29×
$240MMarket cap$112M
expensiveGrowth qualitymixed

Bioneer leads: 2 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

MEDIPOST Co.of which business quality 26 · market factors 18 Bioneerof which business quality 53 · market factors 19
ProfitabilityMargins and returns on capital today
4
40
Quality GrowthAre margins and returns improving?
32
73
CashflowEarnings quality: real cash, not paper profit
4
14
Fin. StrengthBalance sheet, leverage, solvency risk
59
53
InvestmentDisciplined investing over empire-building
72
87
Low VolatilityCalm price path (market factor)
39
55
MomentumPrice trend over the last 3–12 months (market factor)
5
2
52W MomentumDistance to the 52-week high (market factor)
15
5
Net IssuanceBuybacks instead of dilution
0
82

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

MEDIPOST Co.

Asset-BasedKRW 4,269

1 of 1 models see the stock below the current price.

Bioneer

DCF ModelsKRW 11,329
Earnings-BasedKRW 2,991
MultiplesKRW 10,316
Asset-BasedKRW 6,358
Growth DCFKRW 3,943
Economic ProfitKRW 2,991

5 of 12 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

MEDIPOST Co.
Bear KRW 2,708Fair Value KRW 3,628Bull KRW 5,415
KRW 9,850 = current price (white tick)
Bioneer
Bear KRW 4,809Fair Value KRW 8,312Bull KRW 11,032
KRW 6,910 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

MEDIPOST Co. · Health Care

Quality score26 · bottom 25%
Fair value upside-63% · bottom 25%

Bioneer · Health Care

Quality score58 · above median
Fair value upside+20% · Top 25%

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Bioneer as the more attractively valued of the two: MEDIPOST Co. trades at KRW 9,850 versus a fair value of KRW 3,628 (-63%), while Bioneer trades at KRW 6,910 versus KRW 8,312 (+20%).

Bioneer has the higher quality score (58/100).

See the full analysis →
MEDIPOST Co. · Bioneer

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to MEDIPOST Co.

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Bioneer

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.